Lipigem

Lipigem

gemfibrozil

Manufacturer:

Berlin

Distributor:

Littman
Full Prescribing Info
Contents
Gemfibrozil.
Action
Antihyperlipidemic agent.
Pharmacology: Gemfibrozil is a lipid-regulating agent which lowers elevated serum lipids primarily by decreasing serum triglycerides and total serum cholesterol. It reduces elevated plasma concentrations of triglycerides and to a somewhat smaller extent, elevated plasma concentrations of cholesterols, the effect is particularly evident in a reduction of elevated concentrations of very low density lipoproteins. It is also recommended by the American Diabetes Association for type II B dyslipidemias ie, high triglycerides, high LDL, low HDL as first-line therapy.
Indications/Uses
Treatment of hyperlipidemia. Lipigem has been used in long-term treatment and prophylaxis of patients with coronary heart disease.
Dosage/Direction for Use
Usual Dose: 0.6-1.2 g daily in divided doses.
Contraindications
Lipigem should not be given to patients with impaired liver and kidney function or with primary biliary cirrhosis. It should not be given during pregnancy.
Use In Pregnancy & Lactation
Lipigem is contraindicated during pregnancy.
Adverse Reactions
There have been occasional reports of nausea, vomiting, abdominal pain, anorexia, heartburn and diarrhea. Drowsiness, allergy and elevation of serum creatine kinase values have also been reported.
Drug Interactions
Anticoagulants, lovastatin.
Storage
Store at room temperature.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AB04 - gemfibrozil ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Cap 300 mg x 100's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in